Turer Aslan T, Stevens Robert D, Bain James R, Muehlbauer Michael J, van der Westhuizen Johannes, Mathew Joseph P, Schwinn Debra A, Glower Donald D, Newgard Christopher B, Podgoreanu Mihai V
Division of Cardiology, Department of Medicine, Duke University Medical Center, Box 31297, Erwin Rd, Durham, NC 27710, USA.
Circulation. 2009 Apr 7;119(13):1736-46. doi: 10.1161/CIRCULATIONAHA.108.816116. Epub 2009 Mar 23.
Human myocardial metabolism has been incompletely characterized in the setting of surgical cardioplegic arrest and ischemia/reperfusion. Furthermore, the effect of preexisting ventricular state on ischemia-induced metabolic derangements has not been established.
We applied a mass spectrometry-based platform to profile 63 intermediary metabolites in serial paired peripheral arterial and coronary sinus blood effluents obtained from 37 patients undergoing cardiac surgery, stratified by presence of coronary artery disease and left ventricular dysfunction. The myocardium was a net user of a number of fuel substrates before ischemia, with significant differences between patients with and without coronary artery disease. After reperfusion, significantly lower extraction ratios of most substrates were found, as well as significant release of 2 specific acylcarnitine species, acetylcarnitine and 3-hydroxybutyryl-carnitine. These changes were especially evident in patients with impaired ventricular function, who exhibited profound limitations in extraction of all forms of metabolic fuels. Principal component analysis highlighted several metabolic groupings as potentially important in the postoperative clinical course.
The preexisting ventricular state is associated with significant differences in myocardial fuel uptake at baseline and after ischemia/reperfusion. The dysfunctional ventricle is characterized by global suppression of metabolic fuel uptake and limited myocardial metabolic reserve and flexibility after global ischemia/reperfusion stress in the setting of cardiac surgery. Altered metabolic profiles after ischemia/reperfusion are associated with postoperative hemodynamic course and suggest a role for perioperative metabolic monitoring and targeted optimization in cardiac surgical patients.
在心脏手术停搏和缺血/再灌注情况下,人类心肌代谢尚未完全明确。此外,既往心室状态对缺血诱导的代谢紊乱的影响尚未确定。
我们应用基于质谱的平台,对37例接受心脏手术患者的系列配对外周动脉血和冠状窦血流出物中的63种中间代谢物进行分析,这些患者按是否存在冠状动脉疾病和左心室功能障碍进行分层。在缺血前,心肌是多种燃料底物的净使用者,有冠状动脉疾病和无冠状动脉疾病的患者之间存在显著差异。再灌注后,发现大多数底物的提取率显著降低,以及两种特定酰基肉碱即乙酰肉碱和3-羟基丁酰肉碱的显著释放。这些变化在心室功能受损的患者中尤为明显,他们在各种形式代谢燃料的提取方面表现出严重受限。主成分分析突出了几个代谢分组在术后临床过程中可能很重要。
既往心室状态与基线时及缺血/再灌注后心肌燃料摄取的显著差异相关。功能失调的心室的特征是代谢燃料摄取全面受抑,在心脏手术情况下全球缺血/再灌注应激后心肌代谢储备和灵活性有限。缺血/再灌注后代谢谱的改变与术后血流动力学过程相关,并提示围手术期代谢监测和靶向优化在心脏手术患者中的作用。